US4476140A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Composition and method for treatment of glaucoma
Assignee: Yale University
•
Filing: 1983-05-16
•
Granted: 1984-10-09
•
Expires: 2003-05-16
Abstract
Abstract Topical administration of one of the polyoxygenated Labdanes of which forskolin is an example to the eyes produces lower intraocular pressure. The topical application to the eye produces no significant changes in blood pressure or pulse rate. The polyoxygenated Labdanes are effective agents for the treatment of glaucoma.
Inventors
- 👤 Marvin Sears
- 👤 Joseph Caprioli
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-27 12:23
CPC Classifications
A; A61; A61K; A61K31/00; A61K31/33; A61K31/335; A61K31/35
Claims Analysis
Total Claims: 2
Claim 1
Independent Claim
37 words
A method for treating elevated intraocular pressure or glaucoma which comprises topically administering to a patient suffering therefrom a therapeutically effective amount of a material selected from the group consisting of forskolin, coleforsin and polyoxygenated Labdane derivatives.
Claim 2
Independent Claim
37 words
A method for treating elevated intraocular pressure or glaucoma which comprises topically administering to a patient suffering therefrom a therapeutically effective amount of a material selected from the group consisting of forskolin, coleforsin and polyoxygenated Labdane derivatives.
References Cited (Backward Citations)
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1987-10-09 | 1988-04-09 | 1988-10-09 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1991-10-09 | 1992-04-09 | 1992-10-09 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 1995-10-09 | 1996-04-09 | 1996-10-09 | $7700.00 | Window Closed / Lapsed |